top of page
  • MyaLink

The iMZ of Charité Berlin introduces itself

The Integrated Myasthenia Center (iMZ) at Charité, specialized in the treatment and research of myasthenic syndromes, introduces itself in the following image video.

Demonstrating close collaboration with the patient organization for these rare diseases is the regular certification by the German Myasthenia Society (DMG) since 2011. iMZ Berlin provides our patients with long-term, high-quality care in both outpatient and inpatient settings based on interdisciplinary cooperation with specialists from other disciplines and supported by digital healthcare solutions. At Charité, new therapeutic concepts are developed from basic research to clinical trials, leading to the approval of new medications.



Commenting has been turned off.
bottom of page